Merck KGaA (OTCMKTS:MKKGY) Short Interest Down 75.0% in December

Merck KGaA (OTCMKTS:MKKGYGet Free Report) was the target of a significant drop in short interest in December. As of December 15th, there was short interest totalling 400 shares, a drop of 75.0% from the November 30th total of 1,600 shares. Based on an average daily trading volume, of 280,200 shares, the days-to-cover ratio is currently 0.0 days.

Analyst Ratings Changes

Separately, The Goldman Sachs Group initiated coverage on Merck KGaA in a research note on Thursday, September 19th. They issued a “buy” rating for the company.

Read Our Latest Stock Report on MKKGY

Merck KGaA Trading Up 1.0 %

OTCMKTS MKKGY opened at $29.10 on Friday. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.91 and a current ratio of 1.33. The firm has a market capitalization of $18.80 billion, a price-to-earnings ratio of 17.96, a PEG ratio of 2.32 and a beta of 0.93. The company’s 50 day moving average price is $30.98 and its 200 day moving average price is $33.95. Merck KGaA has a one year low of $28.29 and a one year high of $39.17.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Read More

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.